ReViral
Last updated: April 15, 2024
Founder Ken Powell
Country: UK | Funding: $121M (+)
Website: https://www.reviral.co.uk/
reViral is a biotechnology company that develops drugs to treat Respiratory Syncytial Virus (RSV) infection.
Website: https://www.reviral.co.uk/
reViral is a biotechnology company that develops drugs to treat Respiratory Syncytial Virus (RSV) infection.